The comparative analysis of results of conservative and combined treatment was carried out. The study group consisted of 400 patients with stage T3–4N0–3M0 laryngeal cancer who received concurrent chemotherapy and radiation therapy in combination with various physical radiomodifyers. The control group comprised 920 patients treated with the same technique but without systemic polychemotherapy. The 5-year relapse-free and overall survival rates were significantly higher in the study group than in the control group (concervative treatment: 71 % and 86 % versus 37 % and 64.8 %, respectively, р<0,001 and combined treatment: 80 % and 83 % versus 47.4 % and 52 %, respectively(р<0,001). The functional organ was preserved in 71.2 % of locall...
AbstractBackgroundThe standard of care for advanced-stage laryngeal cancer is combined treatment (ch...
The optimal treatment for T3 laryngeal carcinoma (LC) is still a matter of debate. Different therape...
The optimal treatment for T3 laryngeal carcinoma (LC) is still a matter of debate. Different therape...
Laryngeal carcinoma is the 11th commonest form of cancer in men world-wide, with 121,000 new cases i...
The study objective is to evaluate the results of organ-preserving treatment of locally advanced lar...
During the past decades, treatment of laryngeal cancer has changed substantially, mainly due to the ...
Abstract Background: Treatment for laryngeal squamous cell carcinoma (SCC) has been predominantly s...
Since the original data from the Department of Veterans Affairs Laryngeal Cancer Study Group demonst...
BACKGROUND: The primary goal of treatment in advanced laryngeal cancer is to achieve optimal oncolog...
IMPORTANCE OF THE FIELD: Laryngeal cancer has been the model of curative-intent organ-preserving the...
The Dutch Co-operative Head and Neck Oncology Group performed a retrospective, nationwide study of l...
Background. Squamous carcinoma of the larynx is still the most common head and neck cancer in many W...
Object: The therapeutic options for advanced laryngeal-hypopharyngeal cancer have broadened in the l...
Evidence-based medicine integrates the best available data in decision making, with the goal of mini...
OBJECTIVE: Recently, neoadjuvant chemotherapy (CT) and radiation therapy (RT) have been advocate...
AbstractBackgroundThe standard of care for advanced-stage laryngeal cancer is combined treatment (ch...
The optimal treatment for T3 laryngeal carcinoma (LC) is still a matter of debate. Different therape...
The optimal treatment for T3 laryngeal carcinoma (LC) is still a matter of debate. Different therape...
Laryngeal carcinoma is the 11th commonest form of cancer in men world-wide, with 121,000 new cases i...
The study objective is to evaluate the results of organ-preserving treatment of locally advanced lar...
During the past decades, treatment of laryngeal cancer has changed substantially, mainly due to the ...
Abstract Background: Treatment for laryngeal squamous cell carcinoma (SCC) has been predominantly s...
Since the original data from the Department of Veterans Affairs Laryngeal Cancer Study Group demonst...
BACKGROUND: The primary goal of treatment in advanced laryngeal cancer is to achieve optimal oncolog...
IMPORTANCE OF THE FIELD: Laryngeal cancer has been the model of curative-intent organ-preserving the...
The Dutch Co-operative Head and Neck Oncology Group performed a retrospective, nationwide study of l...
Background. Squamous carcinoma of the larynx is still the most common head and neck cancer in many W...
Object: The therapeutic options for advanced laryngeal-hypopharyngeal cancer have broadened in the l...
Evidence-based medicine integrates the best available data in decision making, with the goal of mini...
OBJECTIVE: Recently, neoadjuvant chemotherapy (CT) and radiation therapy (RT) have been advocate...
AbstractBackgroundThe standard of care for advanced-stage laryngeal cancer is combined treatment (ch...
The optimal treatment for T3 laryngeal carcinoma (LC) is still a matter of debate. Different therape...
The optimal treatment for T3 laryngeal carcinoma (LC) is still a matter of debate. Different therape...